A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here

Home: Drug Pipeline   Print This Page 


Cancer Consultants Cancer Drug Pipeline



Supportive Care - Mucositis
Drug Name Class Developer Phase
EN-3247 (immunol)
.1% triclosan Endo Pharmaceuticals III (mucositis)
Epicept MS spray Morphine and lidocaine EpiCept II
Ethyol (amifostine) Chemoprotectant MedImmune II
Evoxac (cevimeline) Cholinergic agent Daiichi Pharmaceutical III, application submitted (dry mouth)
MX8899 Histaminbe topical gel Maxim I
Mucositis Liquid Technology   Access Pharmaceuticals III
Palifermin KGF-1 Keratinocyte growth factor 1 Amgen FDA approval 12-04
P-113-L Antifunagal oral mouth rinse Demegen Inc. II
Pentoxifylline (Lisophylline) Immunomodulator Cell Therapeutics III
Orarinse amlexanox 0.5% GlaxoSmithKline II
Repifermin Keratinocyte growth factor 2 GlaxoSmithKline and Human Genome Sciences

II
RK-0202 Antioxidant N-acetyl-L-cysteine (NAC), RxKinetix, Inc.

III
Saforis (AES-14) L-glutamine solution Aasgen Inc. III
For more information contact us at clinicaltrials@cancerconsultants.com

View Drugs in Pipeline By Disease



© 1998-2007 CancerConsultants.com  All Rights Reserved.